Johnson Johnson articles & resources on Made-in-China.com

JNJ and PCYC Have Won Approval From FDA for Their Breakthrough Therapy Imbruvica

Nov 15, 2013

Johnson & Johnson (JNJ) subsidiary Janssen Biotech and Pharmacyclics (PCYC) have won approval from the US Food and Drug Administration (FDA) for their breakthrough therapy Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma ...

Tags: Johnson&Johnson, MCL Patients

Evotec Said a Collaboration with Johnson&Johnson Innovation for Alzheimer's Drug Discovery

Nov 12, 2013

Evotec has announced a collaboration with the Johnson & Johnson Innovation Center in California to identify new targets for Alzheimer's disease drug discovery and development. Under the terms of the agreement, Janssen Pharmaceuticals ...

Tags: Evotec, Johnson, innovation, Alzheimer

JNJ Announces That Mark B. McClellan,M.D.,Ph.D.,Will Join The Board of Directors on Oct 15

Oct 16, 2013

Johnson & Johnson (NYSE: JNJ) announced today that Mark B. McClellan, M.D., Ph.D., Senior Fellow in Economic Studies, and Director of the Initiative on Value and Innovation in Health Care, Brookings Institution, will join the Board of ...

Tags: Light Industry, Daily Use, Johnson

Johnson & Johnson Has Completed The Acquisition of Aragon Pharmaceuticals

Aug 22, 2013

Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound ...

Tags: Johnson, Health, Medicine

Johnson & Johnson Reported Profits in The Second Quarter of Fiscal 2013

Jul 19, 2013

Johnson & Johnson, a New Jersey-based health care firm, has reported that its profits in the second quarter of fiscal 2013 has more than doubled, partly due to strong sales of medical-devices and medicines. In the second quarter, the net ...

Tags: Health, Medicine

US-Based Johnson & Johnson Has Agreed to Buy Aragon Pharmaceuticals for $1bn

Jun 19, 2013

US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...

Tags: Johnson&Johnson, Medicine

J&J Innovation Has Opened The New California Innovation Center

Jun 7, 2013

Johnson & Johnson (J&J) Innovation has opened the new California Innovation Center to build early stage collaborations with emerging companies in science and technology and advance healthcare. The new centre has the flexibility to adapt ...

Tags: Health, Medicine, healthcare

Johnson&Johnson's Is Planning to Submit More Than 10 New Drugs for Regulatory Approval

May 24, 2013

Johnson & Johnson's Pharmaceuticals unit Janssen is planning to submit more than 10 new products for regulatory approval and extend the brand pipeline of 25 existing drugs by 2017. The late stage products to be submitted for approval ...

Tags: Johnson&Johnson, New Drugs

Johnson & Johnson Has Selected EagleEye Analytics to Provide a Comprehensive Solution

Apr 16, 2013

US Managing General Agent (MGA), Johnson & Johnson has selected EagleEye Analytics to provide a comprehensive predictive analytics solution for monitoring its analytics output and results. The company will deploy EagleEye Analytics' Talon ...

Tags: Analytics Tools, Johnson&Johnson

Johnson & Johnson Has Launched a New Innovation Center in London

Mar 14, 2013

Johnson & Johnson has launched a new Innovation center in London to serve as European hub and accelerate innovation across the healthcare landscape. The London Innovation center is part of Johnson & Johnson Innovation, a division of ...

Tags: Johnson&Johnson, Innovation center, healthcare landscape

Johnson Johnson

Related Products